CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

被引：0
|
作者：
Adla Boumenir
Emmanuel Cognat
Severine Sabia
Claire Hourregue
Matthieu Lilamand
Aline Dugravot
Elodie Bouaziz-Amar
Jean-Louis Laplanche
Jacques Hugon
Archana Singh-Manoux
Claire Paquet
Julien Dumurgier
机构：
[1] Université Paris Diderot,Cognitive Neurology Center, Saint Louis
[2] Sorbonne Paris Cité, Lariboisiere
[3] Paris Descartes University, Fernand Widal Hospital, AP
[4] AP-HP,HP
[5] Sorbonne Paris Cité,INSERM UMR1153, Centre of Research in Epidemiology and StatisticS
[6] Saint Louis - Lariboisiere - Fernand Widal Hospital,Department of biochemistry
[7] AP-HP,Department of Epidemiology and Public Health
[8] University College London,undefined
来源：
Alzheimer's Research & Therapy | / 11卷
关键词：
Alzheimer’s disease; CSF biomarkers; β-amyloid peptide; Mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] β-Adrenergic Receptor, Amyloid β Peptide, and Alzheimer's Disease
    Wang, Dayong
    Xiang, Yang K.
    ADVANCES IN ADRENERGIC RECEPTOR BIOLOGY, 2011, 67 : 205 - 228
  • [22] The amyloid precursor protein of Alzheimer's disease and the Aβ peptide
    Storey, E
    Cappai, R
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1999, 25 (02) : 81 - 97
  • [23] Different CSF β-amyloid processing in Alzheimer’s and Creutzfeldt–Jakob disease
    Brit Mollenhauer
    Hermann Esselmann
    Sigrun Roeber
    Walter J. Schulz-Schaeffer
    Claudia Trenkwalder
    Mirko Bibl
    Petra Steinacker
    Hans A. Kretzschmar
    Jens Wiltfang
    Markus Otto
    Journal of Neural Transmission, 2011, 118 : 691 - 697
  • [24] Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
    Alcolea, Daniel
    Pegueroles, Jordi
    Munoz, Laia
    Camacho, Valle
    Lopez-Mora, Diego
    Fernandez-Leon, Alejandro
    Le Bastard, Nathalie
    Huyck, Els
    Nadal, Alicia
    Olmedo, Veronica
    Sampedro, Frederic
    Montal, Victor
    Vilaplana, Eduard
    Clarimon, Jordi
    Blesa, Rafael
    Fortea, Juan
    Lleo, Alberto
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (09): : 1815 - 1824
  • [25] Decreased CSF clearance and increased brain amyloid in Alzheimer's disease
    Li, Yi
    Rusinek, Henry
    Butler, Tracy
    Glodzik, Lidia
    Pirraglia, Elizabeth
    Babich, John
    Mozley, P. David
    Nehmeh, Sadek
    Pahlajani, Silky
    Wang, Xiuyuan
    Tanzi, Emily B.
    Zhou, Liangdong
    Strauss, Sara
    Carare, Roxana O.
    Theise, Neil
    Okamura, Nobuyuki
    de Leon, Mony J.
    FLUIDS AND BARRIERS OF THE CNS, 2022, 19 (01)
  • [26] Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
    Yi Li
    Henry Rusinek
    Tracy Butler
    Lidia Glodzik
    Elizabeth Pirraglia
    John Babich
    P. David Mozley
    Sadek Nehmeh
    Silky Pahlajani
    Xiuyuan Wang
    Emily B. Tanzi
    Liangdong Zhou
    Sara Strauss
    Roxana O. Carare
    Neil Theise
    Nobuyuki Okamura
    Mony J. de Leon
    Fluids and Barriers of the CNS, 19
  • [27] CSF proteomic signature predicts progression to Alzheimer's disease dementia
    Vromen, Eleonora M.
    del Campo Milan, Marta
    Scheltens, Philip
    Teunissen, Charlotte E.
    Visser, Pieter Jelle
    Tijms, Betty M.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
  • [28] The immune system, amyloid-β peptide, and Alzheimer's disease
    Weksler, ME
    Gouras, G
    Relkin, NR
    Szabo, P
    IMMUNOLOGICAL REVIEWS, 2005, 205 : 244 - 256
  • [29] Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease
    Saido, Takaomi C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [30] In search of pathogenic amyloid β-peptide in familial Alzheimer's disease
    Wolfe, Michael S.
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT A, 2019, 168 : 71 - 78
12345